Technical Analysis for MDWD - MediWound Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 16.63 | -0.89% | -0.15 |
MDWD closed up 6.2 percent on Wednesday, November 20, 2024, on 1.93 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | -0.89% | |
| Earnings Movers | Other | -0.89% | |
| Gapped Up | Strength | -0.89% | |
| Oversold Stochastic | Weakness | -0.89% | |
| Stochastic Buy Signal | Bullish | 5.25% | |
| Earnings Movers | Other | 5.25% | |
| Gapped Up | Strength | 5.25% | |
| Oversold Stochastic | Weakness | 5.25% | |
| Lower Bollinger Band Walk | Weakness | 6.33% | |
| Below Lower BB | Weakness | 6.33% |
| Alert | Time |
|---|---|
| Gap Down Partially Closed | 38 minutes ago |
| Gap Down Closed | 38 minutes ago |
| Gapped Down (Partial) | about 3 hours ago |
| Down 1% | about 3 hours ago |
| Gapped Up (Partial) | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/19/2024
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Acute Pain Burns Connective Tissue Medical Emergencies Necrosis Yavne
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Acute Pain Burns Connective Tissue Medical Emergencies Necrosis Yavne
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.0 |
| 52 Week Low | 8.41 |
| Average Volume | 40,408 |
| 200-Day Moving Average | 16.84 |
| 50-Day Moving Average | 17.25 |
| 20-Day Moving Average | 17.22 |
| 10-Day Moving Average | 16.56 |
| Average True Range | 0.73 |
| RSI (14) | 47.64 |
| ADX | 20.79 |
| +DI | 15.14 |
| -DI | 20.77 |
| Chandelier Exit (Long, 3 ATRs) | 16.24 |
| Chandelier Exit (Short, 3 ATRs) | 17.71 |
| Upper Bollinger Bands | 18.89 |
| Lower Bollinger Band | 15.55 |
| Percent B (%b) | 0.37 |
| BandWidth | 19.37 |
| MACD Line | -0.34 |
| MACD Signal Line | -0.19 |
| MACD Histogram | -0.1509 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.36 | ||||
| Resistance 3 (R3) | 18.20 | 17.53 | 18.09 | ||
| Resistance 2 (R2) | 17.53 | 17.13 | 17.60 | 18.00 | |
| Resistance 1 (R1) | 17.15 | 16.88 | 17.34 | 17.31 | 17.92 |
| Pivot Point | 16.48 | 16.48 | 16.57 | 16.55 | 16.48 |
| Support 1 (S1) | 16.10 | 16.08 | 16.29 | 16.26 | 15.64 |
| Support 2 (S2) | 15.43 | 15.83 | 15.50 | 15.56 | |
| Support 3 (S3) | 15.05 | 15.43 | 15.47 | ||
| Support 4 (S4) | 15.21 |
